Shahla Modir, M.D.
ADDICTION MEDICINE AND PSYCHIATRY
Shahla Modir, M.D.
Dr. Modir is also an Integrative Medicine expert. She is certified by UCLA-HMI to perform medical acupuncture and has completed a 2-year clinical Ayurvedic medicine specialist program. She was a Bravewell scholar and completed the Associate Fellowship at the University of Arizona Program in Integrative Medicine, headed by the famous and well-respected expert Dr. Andrew Weil. She worked as a lecturer with Dr. Deepak Chopra and as an integrative medicine specialist at the Chopra Center. She wrote a chapter for the textbook, Integrative Cardiology, edited by Jack Vogel, M.D., on Ayurvedic approaches to cardiovascular disease. She has worked at multiple residential facilities over the past 10 years and developed the first evidence based psycho-social treatment program with the leading experts from UCLA, Dr. Richard Rawson and Dr. Walter Ling.
Currently, Dr. Modir is the Chief Psychiatrist in the Los Angeles area at Avalon Malibu, Summit Malibu, and Chief Medical Officer at APNLodge providing excellence in inpatient dual diagnosis service. She has served as an Addiction Psychiatry expert on multiple TV shows including The Doctors, Dr. Oz, Dr. Drew Life Changers, and the local ABC news.
Shahla Modir, M.D. completed residency in General Psychiatry at Harbor-UCLA Medical Center and a 2 year fellowship in Addiction Psychiatry at UCLA Medical Center. Dr. Modir is double board certified. This is a rare qualification in the treatment of Addiction and Psychiatry. She is a Diplomat of the American Board of Psychiatry and Neurology for Psychiatry AND Addiction Psychiatry. Dr. Modir is a licensed buprenorphine provider and a dual diagnosis expert. She received an NIH grant to study the effects of acupuncture and motivational interviewing on methamphetamine withdrawal symptoms. She is trained in all of the evidence based psycho-social therapies to treat addiction such as motivational interviewing, cognitive behavioral therapy, and dialectical behavioral therapy. She also has expertise in pharmacogenetic testing and MTHFR mutations. Furthermore, she has worked as medical director and chief psychiatrist for dual diagnosis residential facilities over the past 10 years. She worked with the leading experts from UCLA Integrated Substance Abuse Program to develop inpatient evidence based treatment programs. This blend of experience allows for a well trusted evaluation and treatment of very complicated patients